Latest Strategy News

Emmerson Resources has amended its acquisition scheme deed with Pan African Resources, nominating a Pan African subsidiary as the acquiring party while keeping the share exchange ratio intact.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Elixinol Wellness maintained steady revenue at $3.5 million in Q1 FY26 while boosting gross margins to 45% and reporting a second consecutive quarter of positive underlying operating cash flow.

Kalamazoo Resources reported a robust cash balance of AUD 8.8 million at quarter end, underpinned by a significant equity raise that offsets ongoing exploration and administrative outflows. The company’s funding runway extends beyond three quarters, positioning it to advance its Ashburton Gold Project drilling activities.

The L1 Global Long Short Fund (ASX:GLS) faced a challenging March quarter amid the Iran War-driven oil supply shock but maintains strong performance since inception through active portfolio adjustments and thematic focus on copper, gold, and infrastructure.

VHM Limited has secured A$5 million through a fully underwritten placement priced at A$0.26 per share, funding critical early engineering and procurement ahead of a mid-2026 final investment decision for its Goschen Rare Earth and Mineral Sands Project.

Cooper Metals has acquired the Pyramid Gold Project in North Queensland through an asset swap with AIC Mines, exchanging its Oorindi Project and raising nearly $1 million to fund exploration. The deal adds a high-grade, underexplored gold asset to Cooper’s portfolio, with drilling set to ramp up across multiple projects.

Cooper Metals has swapped its Oorindi Project for the Pyramid Gold Project in North Queensland, a high-grade gold asset in the prolific Drummond Basin. The company plans immediate exploration and a $979,500 capital raise to fund drilling and technical expansion.

Invion Limited is broadening its non-melanoma skin cancer trial to include basal cell carcinoma patients following encouraging safety and efficacy data from squamous cell carcinoma cohorts, targeting the largest skin cancer segment.

Great Southern Mining (ASX:GSN) reported a substantial extension of gold mineralisation at its Golden Boulder discovery in Western Australia, alongside the commencement of deep diamond drilling co-funded by the WA Government. The company also raised A$4.2 million to fuel ongoing exploration.

Jupiter Energy reported US$1.68 million in unaudited oil sales revenue for Q1 2026, with production steady across its Kazakhstan fields and a recent well workover set to boost output.

Starpharma has secured FDA alignment on the clinical development plan for its DEP® HER2 radiotherapy candidate, paving the way for a first-in-human phase 1 study in advanced HER2-positive cancers scheduled for H2 2026.